nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C9—cardial valve—dilated cardiomyopathy	0.0338	0.508	CbGeAlD
Eszopiclone—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0242	0.026	CcSEcCtD
Eszopiclone—Breast pain—Spironolactone—dilated cardiomyopathy	0.018	0.0193	CcSEcCtD
Eszopiclone—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.0178	0.0192	CcSEcCtD
Eszopiclone—Pyelonephritis—Lisinopril—dilated cardiomyopathy	0.0168	0.0181	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0144	0.0155	CcSEcCtD
Eszopiclone—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.014	0.0151	CcSEcCtD
Eszopiclone—Bursitis—Lisinopril—dilated cardiomyopathy	0.0132	0.0143	CcSEcCtD
Eszopiclone—Renal pain—Lisinopril—dilated cardiomyopathy	0.0122	0.0131	CcSEcCtD
Eszopiclone—Apathy—Furosemide—dilated cardiomyopathy	0.0119	0.0129	CcSEcCtD
Eszopiclone—Flat affect—Furosemide—dilated cardiomyopathy	0.0118	0.0127	CcSEcCtD
Eszopiclone—Ataxia—Spironolactone—dilated cardiomyopathy	0.0107	0.0115	CcSEcCtD
Eszopiclone—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.0106	0.0114	CcSEcCtD
Eszopiclone—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0102	0.011	CcSEcCtD
Eszopiclone—Gastritis—Spironolactone—dilated cardiomyopathy	0.0101	0.0108	CcSEcCtD
Eszopiclone—Heartburn—Lisinopril—dilated cardiomyopathy	0.0093	0.01	CcSEcCtD
Eszopiclone—Gout—Furosemide—dilated cardiomyopathy	0.00913	0.00983	CcSEcCtD
Eszopiclone—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00906	0.00975	CcSEcCtD
Eszopiclone—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00888	0.00956	CcSEcCtD
Eszopiclone—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00888	0.00956	CcSEcCtD
Eszopiclone—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00877	0.00944	CcSEcCtD
Eszopiclone—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.0085	0.00915	CcSEcCtD
Eszopiclone—Otitis media—Lisinopril—dilated cardiomyopathy	0.00822	0.00885	CcSEcCtD
Eszopiclone—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00815	0.00878	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00783	0.00843	CcSEcCtD
Eszopiclone—Bladder pain—Furosemide—dilated cardiomyopathy	0.00771	0.0083	CcSEcCtD
Eszopiclone—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00763	0.00821	CcSEcCtD
Eszopiclone—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00744	0.00801	CcSEcCtD
Eszopiclone—Mental disability—Furosemide—dilated cardiomyopathy	0.0074	0.00797	CcSEcCtD
Eszopiclone—Breast pain—Lisinopril—dilated cardiomyopathy	0.00733	0.0079	CcSEcCtD
Eszopiclone—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00723	0.00779	CcSEcCtD
Eszopiclone—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00715	0.0077	CcSEcCtD
Eszopiclone—Viral infection—Lisinopril—dilated cardiomyopathy	0.00708	0.00763	CcSEcCtD
Eszopiclone—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00705	0.00759	CcSEcCtD
Eszopiclone—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00704	0.00758	CcSEcCtD
Eszopiclone—Swelling—Furosemide—dilated cardiomyopathy	0.00702	0.00755	CcSEcCtD
Eszopiclone—Alopecia—Spironolactone—dilated cardiomyopathy	0.00695	0.00749	CcSEcCtD
Eszopiclone—Oliguria—Lisinopril—dilated cardiomyopathy	0.00694	0.00748	CcSEcCtD
Eszopiclone—Gout—Lisinopril—dilated cardiomyopathy	0.00685	0.00738	CcSEcCtD
Eszopiclone—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00659	0.00709	CcSEcCtD
Eszopiclone—Thirst—Furosemide—dilated cardiomyopathy	0.0065	0.007	CcSEcCtD
Eszopiclone—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00648	0.00697	CcSEcCtD
Eszopiclone—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00636	0.00685	CcSEcCtD
Eszopiclone—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00625	0.00673	CcSEcCtD
Eszopiclone—GABRA4—myocardium—dilated cardiomyopathy	0.00621	0.0932	CbGeAlD
Eszopiclone—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00621	0.00669	CcSEcCtD
Eszopiclone—Malaise—Spironolactone—dilated cardiomyopathy	0.00618	0.00665	CcSEcCtD
Eszopiclone—Cystitis—Lisinopril—dilated cardiomyopathy	0.00618	0.00665	CcSEcCtD
Eszopiclone—Photophobia—Lisinopril—dilated cardiomyopathy	0.00601	0.00647	CcSEcCtD
Eszopiclone—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00601	0.00647	CcSEcCtD
Eszopiclone—Irritability—Furosemide—dilated cardiomyopathy	0.00591	0.00636	CcSEcCtD
Eszopiclone—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00578	0.00623	CcSEcCtD
Eszopiclone—Discomfort—Spironolactone—dilated cardiomyopathy	0.00576	0.00621	CcSEcCtD
Eszopiclone—Dehydration—Furosemide—dilated cardiomyopathy	0.00576	0.0062	CcSEcCtD
Eszopiclone—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00572	0.00616	CcSEcCtD
Eszopiclone—Confusional state—Spironolactone—dilated cardiomyopathy	0.00564	0.00607	CcSEcCtD
Eszopiclone—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00563	0.00607	CcSEcCtD
Eszopiclone—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00561	0.00604	CcSEcCtD
Eszopiclone—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00559	0.00602	CcSEcCtD
Eszopiclone—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00557	0.006	CcSEcCtD
Eszopiclone—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00546	0.00588	CcSEcCtD
Eszopiclone—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00529	0.0057	CcSEcCtD
Eszopiclone—Eczema—Lisinopril—dilated cardiomyopathy	0.00517	0.00556	CcSEcCtD
Eszopiclone—Injury—Lisinopril—dilated cardiomyopathy	0.00505	0.00544	CcSEcCtD
Eszopiclone—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00501	0.00539	CcSEcCtD
Eszopiclone—Somnolence—Spironolactone—dilated cardiomyopathy	0.00497	0.00535	CcSEcCtD
Eszopiclone—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00494	0.00532	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00488	0.00526	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00483	0.0052	CcSEcCtD
Eszopiclone—Arthritis—Lisinopril—dilated cardiomyopathy	0.00478	0.00515	CcSEcCtD
Eszopiclone—Drowsiness—Furosemide—dilated cardiomyopathy	0.00477	0.00514	CcSEcCtD
Eszopiclone—TSPO—cardiac ventricle—dilated cardiomyopathy	0.00467	0.0701	CbGeAlD
Eszopiclone—Diplopia—Lisinopril—dilated cardiomyopathy	0.00464	0.005	CcSEcCtD
Eszopiclone—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00464	0.005	CcSEcCtD
Eszopiclone—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00461	0.00496	CcSEcCtD
Eszopiclone—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00461	0.00496	CcSEcCtD
Eszopiclone—Sweating—Furosemide—dilated cardiomyopathy	0.00457	0.00492	CcSEcCtD
Eszopiclone—Face oedema—Lisinopril—dilated cardiomyopathy	0.00448	0.00483	CcSEcCtD
Eszopiclone—Urticaria—Spironolactone—dilated cardiomyopathy	0.00444	0.00478	CcSEcCtD
Eszopiclone—Irritability—Lisinopril—dilated cardiomyopathy	0.00443	0.00477	CcSEcCtD
Eszopiclone—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00442	0.00476	CcSEcCtD
Eszopiclone—TSPO—myocardium—dilated cardiomyopathy	0.0044	0.066	CbGeAlD
Eszopiclone—Ataxia—Lisinopril—dilated cardiomyopathy	0.00437	0.0047	CcSEcCtD
Eszopiclone—GABRA4—heart—dilated cardiomyopathy	0.00434	0.0651	CbGeAlD
Eszopiclone—Dehydration—Lisinopril—dilated cardiomyopathy	0.00432	0.00465	CcSEcCtD
Eszopiclone—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00418	0.0045	CcSEcCtD
Eszopiclone—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00412	0.00444	CcSEcCtD
Eszopiclone—Gastritis—Lisinopril—dilated cardiomyopathy	0.00411	0.00443	CcSEcCtD
Eszopiclone—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00405	0.00436	CcSEcCtD
Eszopiclone—Asthma—Lisinopril—dilated cardiomyopathy	0.00401	0.00432	CcSEcCtD
Eszopiclone—Influenza—Lisinopril—dilated cardiomyopathy	0.00401	0.00432	CcSEcCtD
Eszopiclone—Tinnitus—Furosemide—dilated cardiomyopathy	0.00399	0.0043	CcSEcCtD
Eszopiclone—Pruritus—Spironolactone—dilated cardiomyopathy	0.00396	0.00426	CcSEcCtD
Eszopiclone—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00386	0.00416	CcSEcCtD
Eszopiclone—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00383	0.00412	CcSEcCtD
Eszopiclone—Dysuria—Lisinopril—dilated cardiomyopathy	0.00375	0.00404	CcSEcCtD
Eszopiclone—Dizziness—Spironolactone—dilated cardiomyopathy	0.0037	0.00398	CcSEcCtD
Eszopiclone—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.0037	0.00398	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00366	0.00395	CcSEcCtD
Eszopiclone—Weight increased—Lisinopril—dilated cardiomyopathy	0.00365	0.00393	CcSEcCtD
Eszopiclone—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00365	0.00393	CcSEcCtD
Eszopiclone—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00363	0.00391	CcSEcCtD
Eszopiclone—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00358	0.00386	CcSEcCtD
Eszopiclone—Depression—Lisinopril—dilated cardiomyopathy	0.00357	0.00384	CcSEcCtD
Eszopiclone—Vomiting—Spironolactone—dilated cardiomyopathy	0.00356	0.00383	CcSEcCtD
Eszopiclone—Rash—Spironolactone—dilated cardiomyopathy	0.00353	0.0038	CcSEcCtD
Eszopiclone—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00352	0.00379	CcSEcCtD
Eszopiclone—Vision blurred—Furosemide—dilated cardiomyopathy	0.00351	0.00378	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00351	0.00378	CcSEcCtD
Eszopiclone—Headache—Spironolactone—dilated cardiomyopathy	0.0035	0.00377	CcSEcCtD
Eszopiclone—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00348	0.00375	CcSEcCtD
Eszopiclone—Anaemia—Furosemide—dilated cardiomyopathy	0.00345	0.00371	CcSEcCtD
Eszopiclone—Sweating—Lisinopril—dilated cardiomyopathy	0.00343	0.00369	CcSEcCtD
Eszopiclone—Agitation—Furosemide—dilated cardiomyopathy	0.00343	0.00369	CcSEcCtD
Eszopiclone—Haematuria—Lisinopril—dilated cardiomyopathy	0.00341	0.00367	CcSEcCtD
Eszopiclone—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00338	0.00363	CcSEcCtD
Eszopiclone—Vertigo—Furosemide—dilated cardiomyopathy	0.00335	0.00361	CcSEcCtD
Eszopiclone—Nausea—Spironolactone—dilated cardiomyopathy	0.00332	0.00358	CcSEcCtD
Eszopiclone—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00322	0.00347	CcSEcCtD
Eszopiclone—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00321	0.00346	CcSEcCtD
Eszopiclone—Hallucination—Lisinopril—dilated cardiomyopathy	0.0032	0.00344	CcSEcCtD
Eszopiclone—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00319	0.00343	CcSEcCtD
Eszopiclone—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00316	0.00341	CcSEcCtD
Eszopiclone—Dry mouth—Furosemide—dilated cardiomyopathy	0.0031	0.00334	CcSEcCtD
Eszopiclone—TSPO—heart—dilated cardiomyopathy	0.00307	0.046	CbGeAlD
Eszopiclone—Confusional state—Furosemide—dilated cardiomyopathy	0.00307	0.0033	CcSEcCtD
Eszopiclone—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00304	0.00328	CcSEcCtD
Eszopiclone—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00304	0.00327	CcSEcCtD
Eszopiclone—Tinnitus—Lisinopril—dilated cardiomyopathy	0.003	0.00323	CcSEcCtD
Eszopiclone—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00294	0.00317	CcSEcCtD
Eszopiclone—Anorexia—Furosemide—dilated cardiomyopathy	0.0029	0.00312	CcSEcCtD
Eszopiclone—Chills—Lisinopril—dilated cardiomyopathy	0.00288	0.0031	CcSEcCtD
Eszopiclone—Alopecia—Lisinopril—dilated cardiomyopathy	0.00284	0.00306	CcSEcCtD
Eszopiclone—Tension—Lisinopril—dilated cardiomyopathy	0.00274	0.00296	CcSEcCtD
Eszopiclone—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00274	0.00295	CcSEcCtD
Eszopiclone—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00273	0.00294	CcSEcCtD
Eszopiclone—Nervousness—Lisinopril—dilated cardiomyopathy	0.00272	0.00292	CcSEcCtD
Eszopiclone—Back pain—Lisinopril—dilated cardiomyopathy	0.00271	0.00291	CcSEcCtD
Eszopiclone—Somnolence—Furosemide—dilated cardiomyopathy	0.0027	0.00291	CcSEcCtD
Eszopiclone—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00269	0.0029	CcSEcCtD
Eszopiclone—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00264	0.00285	CcSEcCtD
Eszopiclone—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00264	0.00284	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00263	0.00283	CcSEcCtD
Eszopiclone—TSPO—cardiac atrium—dilated cardiomyopathy	0.00262	0.0394	CbGeAlD
Eszopiclone—Fatigue—Furosemide—dilated cardiomyopathy	0.00262	0.00282	CcSEcCtD
Eszopiclone—Tremor—Lisinopril—dilated cardiomyopathy	0.00262	0.00282	CcSEcCtD
Eszopiclone—Pain—Furosemide—dilated cardiomyopathy	0.0026	0.0028	CcSEcCtD
Eszopiclone—Constipation—Furosemide—dilated cardiomyopathy	0.0026	0.0028	CcSEcCtD
Eszopiclone—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00259	0.00279	CcSEcCtD
Eszopiclone—Anaemia—Lisinopril—dilated cardiomyopathy	0.00258	0.00278	CcSEcCtD
Eszopiclone—Angioedema—Lisinopril—dilated cardiomyopathy	0.00256	0.00275	CcSEcCtD
Eszopiclone—Malaise—Lisinopril—dilated cardiomyopathy	0.00252	0.00272	CcSEcCtD
Eszopiclone—Vertigo—Lisinopril—dilated cardiomyopathy	0.00251	0.00271	CcSEcCtD
Eszopiclone—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00251	0.0027	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00249	0.00268	CcSEcCtD
Eszopiclone—Palpitations—Lisinopril—dilated cardiomyopathy	0.00247	0.00266	CcSEcCtD
Eszopiclone—PTGS1—myocardium—dilated cardiomyopathy	0.00245	0.0367	CbGeAlD
Eszopiclone—Urticaria—Furosemide—dilated cardiomyopathy	0.00242	0.0026	CcSEcCtD
Eszopiclone—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0024	0.00259	CcSEcCtD
Eszopiclone—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0024	0.00259	CcSEcCtD
Eszopiclone—Chest pain—Lisinopril—dilated cardiomyopathy	0.00238	0.00256	CcSEcCtD
Eszopiclone—Myalgia—Lisinopril—dilated cardiomyopathy	0.00238	0.00256	CcSEcCtD
Eszopiclone—Anxiety—Lisinopril—dilated cardiomyopathy	0.00237	0.00256	CcSEcCtD
Eszopiclone—Discomfort—Lisinopril—dilated cardiomyopathy	0.00235	0.00253	CcSEcCtD
Eszopiclone—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00233	0.00251	CcSEcCtD
Eszopiclone—Confusional state—Lisinopril—dilated cardiomyopathy	0.0023	0.00248	CcSEcCtD
Eszopiclone—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00228	0.00246	CcSEcCtD
Eszopiclone—Infection—Lisinopril—dilated cardiomyopathy	0.00227	0.00244	CcSEcCtD
Eszopiclone—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00224	0.00241	CcSEcCtD
Eszopiclone—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00223	0.0024	CcSEcCtD
Eszopiclone—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00221	0.00238	CcSEcCtD
Eszopiclone—Asthenia—Furosemide—dilated cardiomyopathy	0.00218	0.00235	CcSEcCtD
Eszopiclone—Anorexia—Lisinopril—dilated cardiomyopathy	0.00218	0.00234	CcSEcCtD
Eszopiclone—Pruritus—Furosemide—dilated cardiomyopathy	0.00215	0.00232	CcSEcCtD
Eszopiclone—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00208	0.00224	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00208	0.00224	CcSEcCtD
Eszopiclone—Insomnia—Lisinopril—dilated cardiomyopathy	0.00206	0.00222	CcSEcCtD
Eszopiclone—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00205	0.00221	CcSEcCtD
Eszopiclone—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00203	0.00219	CcSEcCtD
Eszopiclone—Somnolence—Lisinopril—dilated cardiomyopathy	0.00203	0.00218	CcSEcCtD
Eszopiclone—Dizziness—Furosemide—dilated cardiomyopathy	0.00201	0.00217	CcSEcCtD
Eszopiclone—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00201	0.00216	CcSEcCtD
Eszopiclone—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00198	0.00214	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00197	0.00212	CcSEcCtD
Eszopiclone—Fatigue—Lisinopril—dilated cardiomyopathy	0.00197	0.00212	CcSEcCtD
Eszopiclone—Constipation—Lisinopril—dilated cardiomyopathy	0.00195	0.0021	CcSEcCtD
Eszopiclone—Pain—Lisinopril—dilated cardiomyopathy	0.00195	0.0021	CcSEcCtD
Eszopiclone—Vomiting—Furosemide—dilated cardiomyopathy	0.00193	0.00208	CcSEcCtD
Eszopiclone—Rash—Furosemide—dilated cardiomyopathy	0.00192	0.00207	CcSEcCtD
Eszopiclone—Dermatitis—Furosemide—dilated cardiomyopathy	0.00192	0.00206	CcSEcCtD
Eszopiclone—Headache—Furosemide—dilated cardiomyopathy	0.00191	0.00205	CcSEcCtD
Eszopiclone—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00188	0.00203	CcSEcCtD
Eszopiclone—CYP2C9—heart—dilated cardiomyopathy	0.00187	0.0281	CbGeAlD
Eszopiclone—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00187	0.00201	CcSEcCtD
Eszopiclone—Urticaria—Lisinopril—dilated cardiomyopathy	0.00181	0.00195	CcSEcCtD
Eszopiclone—Nausea—Furosemide—dilated cardiomyopathy	0.00181	0.00195	CcSEcCtD
Eszopiclone—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.0018	0.00194	CcSEcCtD
Eszopiclone—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0018	0.00194	CcSEcCtD
Eszopiclone—PTGS1—heart—dilated cardiomyopathy	0.00171	0.0256	CbGeAlD
Eszopiclone—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00168	0.00181	CcSEcCtD
Eszopiclone—Asthenia—Lisinopril—dilated cardiomyopathy	0.00164	0.00176	CcSEcCtD
Eszopiclone—Pruritus—Lisinopril—dilated cardiomyopathy	0.00161	0.00174	CcSEcCtD
Eszopiclone—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00156	0.00168	CcSEcCtD
Eszopiclone—Dizziness—Lisinopril—dilated cardiomyopathy	0.00151	0.00163	CcSEcCtD
Eszopiclone—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00146	0.0219	CbGeAlD
Eszopiclone—Vomiting—Lisinopril—dilated cardiomyopathy	0.00145	0.00156	CcSEcCtD
Eszopiclone—Rash—Lisinopril—dilated cardiomyopathy	0.00144	0.00155	CcSEcCtD
Eszopiclone—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00144	0.00155	CcSEcCtD
Eszopiclone—Headache—Lisinopril—dilated cardiomyopathy	0.00143	0.00154	CcSEcCtD
Eszopiclone—Nausea—Lisinopril—dilated cardiomyopathy	0.00136	0.00146	CcSEcCtD
Eszopiclone—GABRG3—Ion channel transport—RYR2—dilated cardiomyopathy	8.76e-05	0.0187	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	8.54e-05	0.0182	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	8.53e-05	0.0182	CbGpPWpGaD
Eszopiclone—GABRG3—Ion channel transport—PLN—dilated cardiomyopathy	8.52e-05	0.0182	CbGpPWpGaD
Eszopiclone—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	8.06e-05	0.0172	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	7.86e-05	0.0168	CbGpPWpGaD
Eszopiclone—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	7.84e-05	0.0167	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	7.38e-05	0.0157	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	7.19e-05	0.0153	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	7.17e-05	0.0153	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	7.17e-05	0.0153	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	7.04e-05	0.015	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	6.98e-05	0.0149	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	6.97e-05	0.0149	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	6.91e-05	0.0148	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	6.86e-05	0.0146	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	6.84e-05	0.0146	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	6.75e-05	0.0144	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	6.74e-05	0.0144	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	6.73e-05	0.0144	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	6.57e-05	0.014	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	6.56e-05	0.014	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	6.42e-05	0.0137	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	6.08e-05	0.013	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.91e-05	0.0126	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	5.9e-05	0.0126	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	5.75e-05	0.0123	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	5.74e-05	0.0122	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.4e-05	0.0115	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.25e-05	0.0112	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.15e-05	0.011	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	5.13e-05	0.011	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.07e-05	0.0108	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	4.94e-05	0.0106	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	4.92e-05	0.0105	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	4.72e-05	0.0101	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	4.53e-05	0.00966	CbGpPWpGaD
Eszopiclone—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	4.36e-05	0.00932	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	4.32e-05	0.00922	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	4.32e-05	0.00922	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	4.19e-05	0.00896	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	4.14e-05	0.00884	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	4.12e-05	0.0088	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	4.05e-05	0.00864	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	4.02e-05	0.00859	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	3.95e-05	0.00843	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	3.95e-05	0.00843	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	3.88e-05	0.00829	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	3.79e-05	0.00808	CbGpPWpGaD
Eszopiclone—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	3.76e-05	0.00803	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	3.45e-05	0.00737	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	3.31e-05	0.00707	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.05e-05	0.00651	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.97e-05	0.00633	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.97e-05	0.00633	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	2.91e-05	0.00621	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.82e-05	0.00602	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.81e-05	0.00599	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	2.78e-05	0.00593	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.76e-05	0.00589	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.73e-05	0.00583	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.73e-05	0.00583	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	2.7e-05	0.00576	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.57e-05	0.00548	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	2.54e-05	0.00542	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.54e-05	0.00542	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.5e-05	0.00533	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.5e-05	0.00533	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.49e-05	0.00532	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.45e-05	0.00523	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.43e-05	0.00518	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.43e-05	0.00518	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.41e-05	0.00514	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.38e-05	0.00509	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.38e-05	0.00509	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	2.37e-05	0.00507	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.35e-05	0.00501	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.34e-05	0.005	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.34e-05	0.005	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.32e-05	0.00496	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	2.29e-05	0.0049	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.28e-05	0.00488	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.28e-05	0.00488	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.26e-05	0.00482	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.21e-05	0.00473	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.18e-05	0.00465	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.12e-05	0.00453	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	2.06e-05	0.00439	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.05e-05	0.00438	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2e-05	0.00426	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2e-05	0.00426	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.94e-05	0.00415	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	1.86e-05	0.00396	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.79e-05	0.00382	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.74e-05	0.00372	CbGpPWpGaD
Eszopiclone—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	1.73e-05	0.00369	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.64e-05	0.0035	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.64e-05	0.00349	CbGpPWpGaD
Eszopiclone—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	1.59e-05	0.0034	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.59e-05	0.00339	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.56e-05	0.00333	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.53e-05	0.00327	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.5e-05	0.00319	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.46e-05	0.00312	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	1.45e-05	0.00311	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	1.42e-05	0.00303	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	1.41e-05	0.00302	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	1.39e-05	0.00296	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	1.36e-05	0.00291	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.34e-05	0.00287	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	1.33e-05	0.00285	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	1.33e-05	0.00284	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	1.31e-05	0.00279	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.23e-05	0.00262	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	1.2e-05	0.00257	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.19e-05	0.00255	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.17e-05	0.0025	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	1.16e-05	0.00248	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.15e-05	0.00246	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	1.13e-05	0.00241	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.12e-05	0.0024	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	1.12e-05	0.00239	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.1e-05	0.00236	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	1.03e-05	0.0022	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	1.02e-05	0.00218	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	9.83e-06	0.0021	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	9.42e-06	0.00201	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	9.15e-06	0.00195	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	8.99e-06	0.00192	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	8.83e-06	0.00189	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	8.61e-06	0.00184	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	7.83e-06	0.00167	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	7.77e-06	0.00166	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	7.53e-06	0.00161	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	7.3e-06	0.00156	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	6.6e-06	0.00141	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	6.32e-06	0.00135	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.24e-06	0.00133	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.07e-06	0.0013	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.02e-06	0.00128	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	5.94e-06	0.00127	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.54e-06	0.00118	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.47e-06	0.00117	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	5.37e-06	0.00115	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.06e-06	0.00108	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.92e-06	0.00105	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.83e-06	0.00103	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.75e-06	0.00101	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.63e-06	0.000989	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	4.17e-06	0.00089	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.05e-06	0.000864	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.03e-06	0.00086	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.92e-06	0.000838	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.92e-06	0.000837	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.54e-06	0.000757	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.53e-06	0.000754	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.28e-06	0.0007	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.19e-06	0.000682	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.87e-06	0.000614	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	2.78e-06	0.000593	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CD36—dilated cardiomyopathy	2.7e-06	0.000577	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AGT—dilated cardiomyopathy	2.44e-06	0.00052	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	1.79e-06	0.000383	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	1.75e-06	0.000373	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	1.57e-06	0.000336	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.46e-06	0.000312	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.42e-06	0.000304	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.28e-06	0.000273	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	9.63e-07	0.000206	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	9.38e-07	0.0002	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	8.44e-07	0.00018	CbGpPWpGaD
